Measuring the quality of outpatient treatment for schizophrenia

Archives of General Psychiatry

Volumn 55, Issue 7, 1998, Pages 611-617

  Young, Alexander S ^a,b,d,e   Sullivan, Greer ^c,d   Burnam, M Audrey ^d   Brook, Robert H ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d RAND CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AKATHISIA; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; OUTPATIENT CARE; PARKINSONISM; PSYCHOSOCIAL CARE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ADULT; AMBULATORY CARE; CASE MANAGEMENT; COMMUNITY MENTAL HEALTH CENTERS; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF HEALTH CARE; SCHIZOPHRENIA; UNITED STATES;

EID: 0031826585     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.7.611     Document Type: Article

References (44)

1. Iglehart JK. Managed care and mental health. N Engl J Med. 1996;334:131-135.
2. Lurie N, Moscovice IS, Finch M, Christianson JB, Popkin MK. Does capitation affect the health of the chronically mentally ill? results from a randomized trial. JAMA. 1992;267:3300-3304.
3. Rogers WH, Wells KB, Meredith LS, Sturm R, Burnam MA. Outcomes for adult outpatients with depression under prepaid or fee-for-service financing. Arch Gen Psychiatry. 1993;50:517-525.
4. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia, N Engl J Med. 1994;331:650-655.
5. Dixon K, Croze C. Improving public/private partnership in managed behavioral healthcare. Behav Healthcare Tomorrow. 1997;6:67-75.
6. Bickman L, Salzer MS. Measuring quality in mental health services. Eval Rev. 1997;21:285-291.
7. Torrey EF, Erdman K, Wolfe SM, Flynn LM. Care of the Seriously Mentally III: A Rating of State Programs. Washington, DC: Public Citizen Health Research Group and the National Alliance for the Mentally III; 1990.
8. Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand Suppl. 1994;382:16-24.
9. McGlynn EA, Norquist GS, Wells KB, Sullivan G, Liberman RP. Quality-of care research in mental health: responding to the challenge. Inquiry. 1988;25: 157-170.
10. American Psychiatric Association Steering Committee. The Expert Consensus Guideline Series: treatment of schizophrenia. J Clin Psychiatry, 1996;57:3-58.
11. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry, 1997;154:1-63.
12. Lehman AF, Steinwachs DM. Translating research into practice: the Schizophrenia Patient Outcomes Research Team treatment recommendations. Schizophr Bull. 1998;24:1-10.
13. Lehman AF, Carpenter WTJ, Goldman HH, Steinwachs DM. Treatment outcomes in schizophrenia: implications for practice, policy, and research. Schizophr Bull. 1995;21:669-675.
14. Kane JM, Marder SR. Psychopharmacologic treatment of schizophrenia. Schizophr Bull. 1993;19:287-302.
15. Dixon LB, Lehman AF, Levine J. Conventional antipsychotic medications for schizophrenia. Schizophr Bull. 1995;21:567-77.
16. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994;151:825-835.
17. Buchanan RW, Clozapine: efficacy and safety. Schizophr Butt. 1995;21: 579-591.
18. Bond GR, Miller LD, Krumwied RD, Ward RS. Assertive case management in three CMHCs: a controlled study. Hosp Community Psychiatry. 1988;39:411-418.
19. Scott JE, Dixon LB. Assertive community treatment and case management for schizophrenia, Schizophr Bull. 1995;21:657-668.
20. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RF, Carter M. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, II: two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry. 1991;48: 340-347.
21. Dixon LB, Lehman AF. Family interventions for schizophrenia. Schizophr Bull. 1995;21:631-643.
22. Brook RH, McGlynn EA, Cleary PD. Quality of health care, part 2: measuring quality of care. N Engl J Med. 1996;335:966-970.
23. Brekke JS. What do we really know about community support programs? strategies for better monitoring, Hosp Community Psychiatry. 1988;39:946-952.
24. Holloway F. Case management for the mentally ill: looking at the evidence. Int J Soc Psychiatry. 1991;37:2-13.
25. Lehman AF, Thompson JW, Dixon LB, Scott JE. Schizophrenia: treatment out-comes research - editors' introduction. Schizophr Bull. 1995;21:561-566.
26. Olfson M. Assertive community treatment: an evaluation of the experimental evidence. Hasp Community Psychiatry, 1990;41:634-641.
27. McGrew JH, Bond GR. Critical ingredients of assertive community treatment: Judgments of the experts. J Ment Health Adm. 1995;22:113-125.
28. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Patient Edition, Version 2.0. New York, NY: New York State Psychiatric Institute; 1995.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
30. Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale. Reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995;166:654-659.
31. Ventura J, Lukoff O, Nuechterlein KH, Liberman RP, Green MF, Shaner A. Brief Psychiatric Rating Scale (BPRS) expanded version (4.0): scales, anchor points and administration manual. Int J Methods Psychiatr Res. 1993;3:227-243.
32. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154: 672-676.
33. Day JC, Wood G, Dewey M, Bentall RP. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry. 1995;166:650-653.
34. Munetz MR, Benjamin S. How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Community Psychiatry. 1988;39:1172-1177.
35. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen AT. Assessment of client-patient satisfaction: development of a general scale. Eval Program Plann. 1979;2:197-207.
36. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, Snyder KS, Doane JA. Expressed emotion, affective style, lithium compliance, and relapse in recent onset mania. Psychopharmacol Bull. 1986;22:628-632.
37. Lehman AF. The well-being of chronic mental patients. Arch Gen Psychiatry. 1983;40:369-373.
38. Ventura J, Green MF, Shaner A, Liberman RP. Training and quality assurance with the Brief Psychiatric Rating Scale: "the drift busters." Int J Methods Psychiatr Res. 1993;3:221-244.
39. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry. 1982;39:486-487.
40. Rubenstein LV, Kahn KL, Reinisch EJ, Sherwood MJ, Rogers WH, Kamberg C, Draper D, Brook RH. Changes in quality of care for five diseases measured by implicit review, 1981 to 1986. JAMA. 1990;264:1974-1979.
41. Kahn KL, Pearson ML, Harrison ER, Desmond KA, Rogers WH, Rubenstein LV, Brook RH, Keeler EB. Health care for black and poor hospitalized Medicare patients. JAMA. 1994;271:1169-1174.
42. Wells KB, Sturm R, Sherbourne CD, Meredith LS. Caring for Depression. Cambridge, Mass: Harvard University Press; 1996.
43. Hannan EL, Kilburn H Jr, Lindsey ML, Lewis R. Clinical versus administrative data bases for CABG surgery: does it matter? Med Care. 1992;30:892-907.
44. Hartz AJ, Kuhn EM. Comparing hospitals that perform coronary artery bypass surgery: the effect of outcome measures and data sources. Am J Public Health. 1994;84:1609-1614.